Geron Corporation (NASDAQ:GERN) Stock Is All Set To Gap-Up: Here is Why

October 12, 2021

Geron Corporation (NASDAQ: GERN) is up 15% in pre-market after announcing the publication of a paper in the Annals of Hematology titled, “Favorable Overall Survival with Imetelstat in Relapsed/Refractory Myelofibrosis Patients Compared with Real World Data.” The paper details statistical analysis of data comparing findings from the IMbark second phase clinical study to Real-World Data. Chief Medical Officer Aleksandra Rizo said that the overall survival in various analyses published in…